Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
3.360
-0.020 (-0.59%)
At close: Nov 17, 2025, 4:00 PM EST
3.400
+0.040 (1.19%)
After-hours: Nov 17, 2025, 4:40 PM EST
Lantern Pharma Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Lantern Pharma stock has a target of 25, which predicts a 644.05% increase from the current stock price of 3.36.
Price Target: $25 (+644.05%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 2, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Lantern Pharma is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +644.05% | Apr 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 25, 2024 |
| EF Hutton | EF Hutton | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +227.38% | Aug 10, 2023 |
| EF Hutton | EF Hutton | Strong Buy Maintains $11 | Strong Buy | Maintains | $11 | +227.38% | Jun 26, 2023 |
| EF Hutton | EF Hutton | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +227.38% | May 25, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.87
from -1.93
EPS Next Year
-2.01
from -1.87
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.92 | -2.07 | |||
| Avg | -1.87 | -2.01 | |||
| Low | -1.79 | -1.93 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.